World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12614000749606
Date of registration: 16/07/2014
Prospective Registration: No
Primary sponsor: Dr. Mehmet AKSOY
Public title: Spinal anesthesia at low and moderately high altitudes: A comparison of anesthetic parameters and hemodynamic changes
Scientific title: A comparison of anesthetic parameters and hemodynamic changes in Males undergoing lower extremity surgery with spinal anesthesia at low and moderately high altitudes.
Date of first enrolment: 01/01/2014
Target sample size: 140
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12614000749606.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Non-randomised trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Safety/efficacy;  
Phase:  Phase 4
Countries of recruitment
Turkey
Contacts
Name: Dr Ilker INCE    
Address:  Department of Anaesthesiology and Reanimation, Faculty of Medicine, Ataturk University, Erzurum, Turkey Postal code: 25240 Turkey
Telephone: +9 0442 3172295
Email: ilkerince1983@yahoo.com
Affiliation: 
Name: Dr Mehmet AKSOY   
Address:  Department of Anaesthesiology and Reanimation, Faculty of Medicine, Ataturk University, Erzurum, Turkey Postal code: 25240 Turkey
Telephone: +9 0442 3172295
Email: drmaksoy@hotmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Male patients with age between 25-40 years, a body mass index between 20-25 kg/m2, ASA (the classification of the American Society of Anesthesiologists) physical status I or II who were scheduled elective lower extremity surgery with spinal anesthesia were included.
Exclusion criteria: Smokers, alcohol consumers, patients with psychiatric or neurological disorders, chronic diseases such as diabetes, a body mass index over 25, ASA physical status III or IV and contraindications to spinal anesthesia such as coagulaton disorder and infection at the puncture site were excluded from the study

Age minimum: 25 Years
Age maximum: 40 Years
Gender: Males
Health Condition(s) or Problem(s) studied
Anaesthesiology - Other anaesthesiology
Spinal anesthesia at low and moderately high altitudes;
Spinal anesthesia at low and moderately high altitudes
Intervention(s)
A total of 140 consecutive male subjects who were admitted to 2 study institutions at Ataturk University, Medical Faculty, Erzurum, Turkey (1890 metres above sea level) and Sakarya University, Medical Faculty, Sakarya, Turkey (31 metres above sea level) between January 1, 2014 and June 30, 2014 and who were scheduled elective lower extremity surgery with spinal anesthesia were enrolled in this study.All participants were permanently resident at moderately high altitude, as well as sea level. Written informed consent was obtained from all participating patients. Demographic characteristics (age, weight and height) and indications for surgery of the patients were recorded. Before transfer to the operating room, all patients received ringer’s lactate solution intravenously at 1 to 2 ml/kg/hour via 18-gauge cannula in a forearm peripheral vein. Standard monitoring included non-invasive arterial pressure, electrocardiography and pulse oximetry was established for all patients in the operating room. Before the procedure of anesthesia, each patient was premedicated with intravenous (iv) fentanyl (0.1 µg/kg) and midazolam (2 mg). After skin infiltration with 2% lidocain, 26-gauge Quincke's needle was inserted through the L2-3/ L3-4 intervertebral space of sitting position patient. Once free flow of cerebrospinal fluid was obtained, hyperbaric bupivacaine 0.5%, 9mg (1.8mL) was injected intrathecally. Then, the patient was enrolled in the supine position. Sensory block level was tested using pinprick tests and motor block level was evaluated with Modified Bromage scale (scale 0 = full flexion of foot, knee and hip, ie, no motor block; scale 1 = full flexion of foot and knee, unable to hip flexion; scale 2 = full flexion of foot, unable to knee and hip flexion; scale 3 = total m
Primary Outcome(s)
To detect the differences, if any, between moderately highlanders and lowlanders in terms of hemodynamic parameters under neuroxial anesthesia via standard monitorization (Datex-Ohmeda, Helsinki, Finland). [During the operation, patients' mean arterial blood pressure (MABP), heart rate (HR) and oxygen saturation were recorded every 5 minutes using a standard monitorization (Datex-Ohmeda, Helsinki, Finland). ]
Secondary Outcome(s)
anaesthetic complications such as PDPH (increased pain intensity upon standing up from a supine position). [during surgery and postoperative period for up to 24 hours.]
motor block duration [the time from local anaesthetic injection to complete motor function recovery.Complete motor block was defined as a Bromage score of 3. ]
duration of the block procedure [the time from the start of the anesthetic procedure to the development of full motor block. Complete motor block was defined as a Bromage score of 3. ]
duration of surgery [the time from the start of the surgical incision to the completion of surgery]
Highest sensory block level was assessed using Modified Bromage scale. [during surgery (the values in 5,10,20,30,90 th minutes). ]
sensory block time [from local anesthetic injection to the recovery of S2 dermatom]
Secondary ID(s)
None
Source(s) of Monetary Support
Dr.Mehmet AKSOY
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Ataturk University Medical Faculty Ethical Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history